CHRISTOPHER MINNIER: Open Payments
NPI 1417348418 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 7 payments from 6 companies in 2025. Trend: 2023 $46 · 2024 $78 · 2025 $182
Food & beverage: $114Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Caris MPI, Inc. | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Celgene Corporation | 1 | $13 |
Products named: IMFINZI, MI CANCER SEEK, Trodelvy, KISQALI, OPDIVO.
Industry payments across PA — which companies pay providers there.
